The Business of Making a Baby
By Lindsey J. Smith,
San Francisco Magazine [cites CGS' Marcy Darnovsky]
| 03. 23. 2018
After spending her 20s as an aid worker in Africa and India, Helena moved to the Bay Area in 2012, when she was 31. She wanted to apply her public health background to the startup world, so she worked for one health-tech company and then another. She quickly adjusted to life in the city and formed a group of single female friends whose ambitions closely matched her own. To Helena, these young women epitomized the freedom and boundless potential of Silicon Valley: They had worked hard, mapped out paths to promotions, and risen in their fields. They lived as mistresses of their own destinies.
But as their early 30s melted into their mid-30s, a question loomed like storm clouds on the horizon: How and when would any of them have children? Helena (who asked that her last name not be used) and her friends began discussing the option of egg freezing. A consensus soon formed: It was insurance for your future. It let you take your time and find the perfect partner. It would buy you more years to advance...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...